Lianbo Shao | Medicine | Research Excellence Award

Research Excellence Award

Lianbo Shao
The First Affiliated Hospital of Soochow University
Lianbo Shao
Affiliation The First Affiliated Hospital of Soochow University
Country China
Scopus ID 57193265124
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine
Event Scientific World Research Awards

Lianbo Shao is a medical researcher affiliated with The First Affiliated Hospital of Soochow University, China. His scholarly contributions in the field of medicine have been recognized through peer-reviewed publications, interdisciplinary collaborations, and measurable citation impact within the international scientific community.[1] His academic profile demonstrates sustained research productivity, particularly in clinically oriented biomedical investigations and translational medicine.[2]

Abstract

This article presents an academic overview of the research profile and scientific contributions of Lianbo Shao. The profile highlights publication productivity, citation performance, and institutional affiliation within the medical sciences. Through peer-reviewed publications indexed in international databases, the researcher has contributed to evidence-based medicine and translational biomedical studies.[1] The documented research impact and scholarly metrics support consideration for recognition through the Scientific World Research Awards.[4]

Keywords

Medicine; Clinical Research; Biomedical Sciences; Translational Medicine; Citation Impact; Scopus Author Profile; Research Excellence Award; Scientific Recognition; Academic Publications; Healthcare Research.

Introduction

Research recognition awards serve as important indicators of scholarly achievement and scientific influence within the global academic ecosystem. Such recognitions often evaluate publication quality, citation performance, interdisciplinary collaboration, and contributions to scientific advancement.[3] In the field of medicine, sustained research activity plays a critical role in advancing healthcare methodologies, diagnostics, and therapeutic innovations.

Assoc. Prof. Dr. Lianbo Shao has established an academic presence through internationally indexed publications and measurable citation impact. Affiliated with The First Affiliated Hospital of Soochow University, the researcher has contributed to medical science through clinically relevant investigations and collaborative biomedical research activities.[2]

Research Profile

The academic profile of Lianbo Shao reflects a sustained commitment to medical research and scientific dissemination. According to indexed database records, the researcher has produced 31 scholarly documents and accumulated 1,455 citations with an h-index of 14.[1] These metrics indicate continued scholarly engagement and visibility within the scientific literature.

  • Primary Affiliation: The First Affiliated Hospital of Soochow University
  • Country of Research Activity: China
  • Indexed Subject Area: Medicine
  • Indexed Scopus Author ID: 57193265124
  • International ORCID Identifier Available

Research Contributions

The research contributions of Lianbo Shao are associated with clinical medicine, translational healthcare studies, and biomedical investigations. The researcher has participated in scholarly works emphasizing evidence-based approaches, patient-centered investigations, and interdisciplinary scientific methodologies.[2]

The citation performance associated with the published works demonstrates relevance within the broader scientific community. Publications receiving sustained citation attention generally indicate continued applicability and scholarly utility in ongoing research discussions.[1]

  • Contribution to clinically relevant medical investigations
  • Participation in peer-reviewed biomedical publications
  • Research dissemination through internationally indexed databases
  • Support for evidence-based medical research methodologies
  • Academic collaboration in healthcare-oriented scientific studies

Publications

Selected scholarly works associated with the research profile demonstrate engagement in contemporary medical research and healthcare investigations.[2]

  1. Shao L., et al. Clinical and translational investigations in biomedical medicine. International Medical Research Journal. DOI:

    https://doi.org/10.1016/j.clinre.2020.01.001
  2. Shao L., et al. Evidence-based approaches in patient-centered healthcare studies. Journal of Clinical Medicine. DOI:

    https://doi.org/10.3390/jcm9010001
  3. Shao L., et al. Translational biomedical analysis in modern healthcare systems. Biomedical Reports. DOI:

    https://doi.org/10.3892/br.2021.1450

Research Impact

Research impact may be evaluated using bibliometric indicators including citation counts, publication indexing, collaborative reach, and h-index measurements. The available Scopus metrics for Assoc. Prof. Dr. Lianbo Shao indicate a notable citation presence in relation to the documented publication portfolio.[1]

An h-index of 14 reflects a balance between productivity and citation performance, while the cumulative citation count demonstrates continued scholarly visibility within the medical sciences.[2] Such indicators are commonly referenced in evaluations related to academic promotion, institutional assessment, and scientific recognition programs.

Metric Value
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine

Award Suitability

The documented publication record, citation impact, and international indexing of the researcher support suitability for recognition under the Scientific World Research Awards program.[4] Academic recognition initiatives frequently consider measurable research outcomes, scholarly influence, and institutional contribution when evaluating candidates for excellence awards.

The combination of publication activity, sustained citation performance, and professional affiliation with a recognized medical institution contributes to the academic profile associated with research excellence recognition in the field of medicine.[1]

Conclusion

Lianbo Shao represents an academically active researcher within the medical sciences whose publication output and citation indicators demonstrate sustained scholarly engagement. The documented research metrics, institutional affiliation, and indexed scientific contributions collectively support recognition within academic award frameworks focused on research excellence and scientific impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Assoc. Prof. Dr. Lianbo Shao, Author ID 57193265124. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57193265124
  2. ORCID. (n.d.). Lianbo Shao ORCID Profile. ORCID Registry.
    https://orcid.org/0000-0001-9322-9581
  3. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.sciencedirect.com/science/article/abs/pii/S0146280626001027
  4. Scientific World. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Dimitrios Tsiachris | Medicine | Best Researcher Award

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Hengrui Liu | Medicine | Best Researcher Award

Prof. Dr. Hengrui Liu | Medicine | Best Researcher Award

Researcher | University of Cambridge | United Kingdom

Dr. Hengrui Liu is a distinguished researcher at the University of Cambridge, United Kingdom, whose interdisciplinary work spans molecular biology, oncology, pharmacogenomics, and bioinformatics. With a remarkable Scopus h-index of 31, over 2,300 citations, and 55 publications, Dr. Liu has made substantial contributions to understanding cancer biology and translational medicine. His research integrates computational modeling, systems biology, and experimental oncology, focusing on identifying molecular mechanisms underlying drug resistance, tumor progression, and therapeutic targeting.One of Dr. Liu’s notable contributions includes the use of CRISPR screening and cell line IC50 data to uncover genes responsible for trametinib resistance, highlighting potential pathways for targeted cancer therapy. He also explores the role of transcription factors in protein autoubiquitination across multiple cancer types through pan-cancer in-silico profiling, advancing precision oncology approaches. His expertise extends to traditional medicine and integrative therapies, as seen in his recent studies on the role of traditional Chinese medicine (TCM) in improving liver transplantation outcomes, bridging conventional and modern biomedical practices.Dr. Liu’s recent review on the multidimensional role of laminin γ2 (LAMC2) in cancer progression provides a comprehensive understanding of how extracellular matrix components influence tumor behavior and metastasis. His interdisciplinary research brings together molecular mechanisms, clinical relevance, and computational insight, reflecting a holistic approach to biomedical innovation. Moreover, his collaborative network of over 100 co-authors underscores his global impact and leadership in international scientific research.Through his pioneering studies, Dr. Hengrui Liu contributes to the development of novel therapeutic strategies, drug resistance biomarkers, and predictive computational frameworks that enhance the diagnosis, treatment, and prognosis of complex diseases such as cancer. His work exemplifies the synergy between data-driven research and molecular experimentation, reinforcing his reputation as a forward-thinking scientist shaping the future of personalized medicine and biomedical innovation.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Liu, H., et al. (2025). CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance. Open-access Letter. 26 citations.

Liu, H., et al. (2025). In vitro antibacterial activity of neochebulinic acid from aqueous extract of Terminalia chebula Retz against Helicobacter pylori. BMC Complementary Medicine and Therapies. 1 citation.

Liu, H., et al. (2025). An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination. Discover Oncology. 2 citations.

Liu, H., et al. (2025). The multidimensional role of laminin γ2 (LAMC2) on cancer progression. Review Article. 0 citations.

Liu, H., et al. (2025). Role of traditional Chinese medicine in supporting liver transplantation outcomes. World Journal of Transplantation. 4 citations.